| 'IAP Immunization Timetable 2014' I. IAP recommended vaccines for routine use |
||
|---|---|---|
| Age (completed weeks/months/years) |
Vaccines | Comments/Notes |
| Birth | -BCG -OPV 0 -Hep-B 1 |
Administer these vaccines to all newborns before hospital Discharge |
| 6 weeks | -DTwP 1 -IPV 1 -Hep-B 2 -Hib 1 -Rotavirus 1 -PCV 1 |
DTP: • DTaP vaccine/combinations should preferably be avoided for the primary series • DTaP vaccine/combinations should be preferred in certain specific circumstances/conditions only • No need of repeating/giving additional doses of whole- cell pertussis (wP) vaccine to a child who has earlier completed their primary schedule with acellular pertussis (aP) vaccine-containing products Polio: • All doses of IPV may be replaced with OPV if administration of the former is unfeasible Polio: • All doses of IPV may be replaced with OPV if administration of the former is unfeasible • Additional doses of OPV on all supplementary immunization activities (SIAs) • Two doses of IPV instead of 3 for primary series if started at 8 weeks, and 8 weeks interval between the doses • No child should leave the facility without polio immunization (IPV or OPV), if indicated by the schedule Rotavirus: • 2 doses of RV1 and 3 doses of RV5 • RV1 should be employed in 10 & 14 week schedule, instead of 6 & 10 week • 10 & 14 week schedule of RV1 is found to be far more immunogenic than existing 6 & 10 week schedule |
| 10 weeks | -DTwP 2 -IPV 2 -Hib 2 *Rotavirus 2 -PCV2 |
Rotavirus: If RV1 is chosen, the first dose should be given at 10 weeks |
| 14 weeks | -DTwP 3 -IPV 3 -Hib 3 *Rotavirus 3 -PCV 3 |
Rotavirus: • Only 2 doses of RV1 are recommended at present. • If RV1 is chosen, the 2nd dose should be given at 14 Weeks |
| 6 Months | -OPV 1 -Hep-B 3 |
Hepatitis-B: The final (third or fourth) dose in the HepB vaccine series should be administered no earlier than age 24 weeks and at least 16 weeks after the first dose. |
| 9 Months | -OPV 2 -MMR-1 |
MMR: • Measles-containing vaccine ideally should not be administered before completing 270 days or 9 months of life; • The 2nd dose must follow in 2nd year of life; • No need to give stand-alone measles vaccine |
| 9 to 12 Months | -Typhoid Conjugate Vaccine | • Currently, two typhoid conjugate vaccines, Typbar-TCV® and PedaTyph® available in Indian market; • PedaTyph® is not yet approved; the recommendation is applicable to Typbar-TCV® only • An interval of at least 4 weeks with the MMR vaccine should be maintained while administering this vaccine • Should follow a booster at 2 years of age |
| 12 Months | -Hep-A 1 | Hepatitis A: • Single dose for live attenuated H2-strain Hep-A vaccine • Two doses for all killed Hep-A vaccines are recommended now |
| 15 Months | -MMR 2 -Varicella 1 -PCV booster |
MMR: • The 2nd dose must follow in 2nd year of life • However, it can be given at anytime 4-8 weeks after the 1st dose Varicella: The risk of breakthrough varicella is lower if given 15 months onward |
| 6 to 18 Months | -DTwP B1/DTaP B1 -IPV B1 -Hib B1 |
The first booster (4th dose) may be administered as early as age 12 months, provided at least 6 months have elapsed since the third dose. DTP: • First & second boosters should preferably be of DTwP • Considering a higher reactogenicity of DTwP, DTaP can be considered for the boosters |
| 18 Months | Hep-A 2 | Hepatitis A: 2nd dose for killed vaccines; only single dose for live attenuated H2-strain vaccine |
| 2 Years | Typhoid booster | • Either Typbar-TCV® or Vi-polysaccharide (Vi-PS) can be employed as booster; • Typhoid revaccination every 3 years, if Vi-polysaccharide vaccine is used • Need of revaccination following a booster of Typbar- TCV® not yet determined |
| 4 to 6 Years | -DTwP B2/DTaP B2 -OPV 3 -Varicella 2 -Typhoid booster |
Varicella: the 2nd dose can be given at anytime 3 months after the 1st dose. |
| 10 to 12 Years | -Tdap/Td -HPV |
Tdap: is preferred to Td followed by Td every 10 years. HPV: • Only 2 doses of either of the two HPV vaccines for adolescent / preadolescent girls aged 9-14 years; • For girls 15 years and older, and immunocompromised individuals 3 doses are recommended • For two-dose schedule, the minimum interval between doses should be 6 months. • For 3 dose schedule, the doses can be administered at 0, 1-2 (depending on brands) and 6 months |
II.IAP recommended vaccines for High-risk* children(Vaccines under special circumstances)
*High-risk category of children:
